• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

为了更好地理解稳定剂在QESD结晶过程中的作用。

Towards a better understanding of the role of stabilizers in QESD crystallizations.

作者信息

Hansen Jerome, Kleinebudde Peter

机构信息

Institute of Pharmaceutics and Biopharmaceutics, Heinrich Heine Universitaet Duesseldorf, Universitaetsstrasse 1, 40225, Duesseldorf, Germany.

出版信息

Pharm Res. 2022 Dec;39(12):3123-3136. doi: 10.1007/s11095-022-03212-2. Epub 2022 Mar 9.

DOI:10.1007/s11095-022-03212-2
PMID:35266086
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9780136/
Abstract

Quasi-emulsion solvent-diffusion crystallization (QESD) is a type of spherical crystallization which can be used as a particle design method to improve the flowability and micromeritic properties of drugs or excipients. Spherical particles are generated by dispersing a solvent phase in an antisolvent so that a transient emulsion is formed. Within the droplets the material can crystallize and agglomerate into spherical, hollow particles. Surfactants, such as surface-active polymers like hypromellose, are often required to stabilize the quasi-emulsion. To gain further understanding for the role of the stabilizer, a new screening-method was developed which compared different surface active polymers in solution at similar dynamic viscosities rather than at a set concentration. The dynamic viscosities of a low-viscosity grade hypromellose solution used in the previous publications describing the QESD crystallization of metformin hydrochloride by the authors was used as a target value. QESD crystallizations of metformin hydrochloride (MF) and celecoxib showed that the type of stabilizer and whether it is dissolved in the solvent or antisolvent has an effect on the agglomerates. For MF, the type of hypromellose used can have a significant influence on the properties of the agglomerates. More polymers could be used to stabilize the transient emulsion of celecoxib than previously found in literature. Furthermore, QESD crystallizations seem to be more robust when the stabilizer is dissolved in the antisolvent, however this can lead to a reduced drug load of the agglomerates.

摘要

准乳液溶剂扩散结晶法(QESD)是一种球形结晶方法,可作为一种颗粒设计方法来改善药物或辅料的流动性和粉体学性质。通过将溶剂相分散在反溶剂中形成瞬时乳液,从而生成球形颗粒。在液滴内部,物质可以结晶并聚集成球形空心颗粒。通常需要表面活性剂,如羟丙甲纤维素等表面活性聚合物来稳定准乳液。为了进一步了解稳定剂的作用,开发了一种新的筛选方法,该方法比较了具有相似动态粘度而非设定浓度的溶液中的不同表面活性聚合物。作者在之前描述盐酸二甲双胍QESD结晶的出版物中使用的低粘度级羟丙甲纤维素溶液的动态粘度被用作目标值。盐酸二甲双胍(MF)和塞来昔布的QESD结晶表明,稳定剂的类型以及它是溶解在溶剂中还是反溶剂中会对聚集体产生影响。对于MF,所用羟丙甲纤维素的类型会对聚集体的性质产生显著影响。可用于稳定塞来昔布瞬时乳液的聚合物比文献中先前发现的更多。此外,当稳定剂溶解在反溶剂中时,QESD结晶似乎更稳定,然而这可能会导致聚集体的载药量降低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/456a/9780136/9f6a1bc94b2b/11095_2022_3212_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/456a/9780136/9ef2d698e611/11095_2022_3212_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/456a/9780136/9110b7552739/11095_2022_3212_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/456a/9780136/8a584f0d71d9/11095_2022_3212_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/456a/9780136/7c9d2cdb8c95/11095_2022_3212_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/456a/9780136/34a6808f4ffb/11095_2022_3212_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/456a/9780136/f6a59940bbf9/11095_2022_3212_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/456a/9780136/7df47904e94e/11095_2022_3212_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/456a/9780136/db7f015335a3/11095_2022_3212_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/456a/9780136/82c3df5f7f7d/11095_2022_3212_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/456a/9780136/ccfe737a76d2/11095_2022_3212_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/456a/9780136/7089eca9b605/11095_2022_3212_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/456a/9780136/9f6a1bc94b2b/11095_2022_3212_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/456a/9780136/9ef2d698e611/11095_2022_3212_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/456a/9780136/9110b7552739/11095_2022_3212_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/456a/9780136/8a584f0d71d9/11095_2022_3212_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/456a/9780136/7c9d2cdb8c95/11095_2022_3212_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/456a/9780136/34a6808f4ffb/11095_2022_3212_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/456a/9780136/f6a59940bbf9/11095_2022_3212_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/456a/9780136/7df47904e94e/11095_2022_3212_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/456a/9780136/db7f015335a3/11095_2022_3212_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/456a/9780136/82c3df5f7f7d/11095_2022_3212_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/456a/9780136/ccfe737a76d2/11095_2022_3212_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/456a/9780136/7089eca9b605/11095_2022_3212_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/456a/9780136/9f6a1bc94b2b/11095_2022_3212_Fig12_HTML.jpg

相似文献

1
Towards a better understanding of the role of stabilizers in QESD crystallizations.为了更好地理解稳定剂在QESD结晶过程中的作用。
Pharm Res. 2022 Dec;39(12):3123-3136. doi: 10.1007/s11095-022-03212-2. Epub 2022 Mar 9.
2
Improving flowability and reducing storage agglomeration of metformin hydrochloride through QESD crystallization.通过 QESD 结晶改善盐酸二甲双胍的流动性并减少储存结块。
Eur J Pharm Biopharm. 2021 Feb;159:170-176. doi: 10.1016/j.ejpb.2021.01.004. Epub 2021 Jan 15.
3
Particle design of tolbutamide by the spherical crystallization technique. III. Micromeritic properties and dissolution rate of tolbutamide spherical agglomerates prepared by the quasi-emulsion solvent diffusion method and the solvent change method.采用球形结晶技术对甲苯磺丁脲进行颗粒设计。III. 用准乳液溶剂扩散法和溶剂变更法制备的甲苯磺丁脲球形附聚物的粉体学性质及溶出速率
Chem Pharm Bull (Tokyo). 1990 Mar;38(3):733-9. doi: 10.1248/cpb.38.733.
4
Increasing the Batch Size of a QESD Crystallization by Using a MSMPR Crystallizer.使用MSMPR结晶器增加QESD结晶的批量大小。
Pharmaceutics. 2022 Jun 9;14(6):1227. doi: 10.3390/pharmaceutics14061227.
5
Enhancing flowability of lamivudine through quasi-emulsion solvent-diffusion (QESD) crystallization: A comprehensive study on surfactant impact, particle morphology by QbD concepts and tablet compression challenges.通过准乳液溶剂扩散(QESD)结晶提高拉米夫定的流动性:表面活性剂影响、QbD 概念下的颗粒形态以及片剂压缩挑战的综合研究。
Eur J Pharm Sci. 2024 Sep 1;200:106835. doi: 10.1016/j.ejps.2024.106835. Epub 2024 Jun 20.
6
Reduction of Punch-Sticking Propensity of Celecoxib by Spherical Crystallization via Polymer Assisted Quasi-Emulsion Solvent Diffusion.球形结晶通过聚合物辅助准乳液溶剂扩散降低塞来昔布的冲压倾向。
Mol Pharm. 2020 Apr 6;17(4):1387-1396. doi: 10.1021/acs.molpharmaceut.0c00086. Epub 2020 Mar 24.
7
Agglomeration of celecoxib by quasi-emulsion solvent diffusion method without stabilizer: effect of good solvent.无稳定剂准胶束溶剂扩散法聚集塞来昔布:良溶剂的影响。
Pharm Dev Technol. 2018 Dec;23(10):1037-1046. doi: 10.1080/10837450.2016.1270965. Epub 2017 Jan 12.
8
Enabling the direct compression of metformin hydrochloride through QESD crystallization.通过 QESD 结晶使盐酸二甲双胍能够直接压缩。
Int J Pharm. 2021 Aug 10;605:120796. doi: 10.1016/j.ijpharm.2021.120796. Epub 2021 Jun 11.
9
Definition of a solvent system for spherical crystallization of salbutamol sulfate by quasi-emulsion solvent diffusion (QESD) method.通过准乳液溶剂扩散(QESD)法进行硫酸沙丁胺醇球形结晶的溶剂体系定义。
J Pharm Sci. 2001 Oct;90(10):1620-7. doi: 10.1002/jps.1112.
10
Microstructures and pharmaceutical properties of ferulic acid agglomerates prepared by different spherical crystallization methods.不同球形结晶方法制备阿魏酸聚集物的微观结构和药物性能。
Int J Pharm. 2020 Jan 25;574:118914. doi: 10.1016/j.ijpharm.2019.118914. Epub 2019 Dec 4.

引用本文的文献

1
Increasing the Batch Size of a QESD Crystallization by Using a MSMPR Crystallizer.使用MSMPR结晶器增加QESD结晶的批量大小。
Pharmaceutics. 2022 Jun 9;14(6):1227. doi: 10.3390/pharmaceutics14061227.

本文引用的文献

1
Enabling the direct compression of metformin hydrochloride through QESD crystallization.通过 QESD 结晶使盐酸二甲双胍能够直接压缩。
Int J Pharm. 2021 Aug 10;605:120796. doi: 10.1016/j.ijpharm.2021.120796. Epub 2021 Jun 11.
2
Improving flowability and reducing storage agglomeration of metformin hydrochloride through QESD crystallization.通过 QESD 结晶改善盐酸二甲双胍的流动性并减少储存结块。
Eur J Pharm Biopharm. 2021 Feb;159:170-176. doi: 10.1016/j.ejpb.2021.01.004. Epub 2021 Jan 15.
3
Reduction of Punch-Sticking Propensity of Celecoxib by Spherical Crystallization via Polymer Assisted Quasi-Emulsion Solvent Diffusion.
球形结晶通过聚合物辅助准乳液溶剂扩散降低塞来昔布的冲压倾向。
Mol Pharm. 2020 Apr 6;17(4):1387-1396. doi: 10.1021/acs.molpharmaceut.0c00086. Epub 2020 Mar 24.
4
Microstructures and pharmaceutical properties of ferulic acid agglomerates prepared by different spherical crystallization methods.不同球形结晶方法制备阿魏酸聚集物的微观结构和药物性能。
Int J Pharm. 2020 Jan 25;574:118914. doi: 10.1016/j.ijpharm.2019.118914. Epub 2019 Dec 4.
5
Direct Compression Tablet Containing 99% Active Ingredient-A Tale of Spherical Crystallization.含 99%活性成分的直接压片-球形结晶的故事。
J Pharm Sci. 2019 Apr;108(4):1396-1400. doi: 10.1016/j.xphs.2018.11.015. Epub 2018 Nov 15.
6
Comparative evaluation of powder flow parameters with reference to particle size and shape.粉末流动参数的比较评估与粒度和形状有关。
Int J Pharm. 2018 Aug 25;547(1-2):133-141. doi: 10.1016/j.ijpharm.2018.05.059. Epub 2018 May 24.
7
Agglomeration of Celecoxib by Quasi Emulsion Solvent Diffusion Method: Effect of Stabilizer.通过准乳液溶剂扩散法制备塞来昔布团聚体:稳定剂的影响
Adv Pharm Bull. 2016 Dec;6(4):607-616. doi: 10.15171/apb.2016.075. Epub 2016 Dec 22.
8
Agglomeration of celecoxib by quasi-emulsion solvent diffusion method without stabilizer: effect of good solvent.无稳定剂准胶束溶剂扩散法聚集塞来昔布:良溶剂的影响。
Pharm Dev Technol. 2018 Dec;23(10):1037-1046. doi: 10.1080/10837450.2016.1270965. Epub 2017 Jan 12.
9
Spherical agglomerates of lactose with enhanced mechanical properties.具有增强机械性能的乳糖球形团聚体。
Int J Pharm. 2017 Jan 10;516(1-2):247-257. doi: 10.1016/j.ijpharm.2016.11.040. Epub 2016 Nov 17.
10
The effect of moisture on the flowability of pharmaceutical excipients.水分对药用辅料流动性的影响。
AAPS PharmSciTech. 2014 Feb;15(1):65-74. doi: 10.1208/s12249-013-0036-0. Epub 2013 Oct 3.